Application Notes & Case Studies

  1. How Sponsors Can Leverage New Technologies To Lower Trial Costs 1/6/2025

    This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.

  2. How eSource Reduced Benchmark's Protocol Deviations By Almost 40% 1/6/2025

    Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.

  3. Drive Superior Enrollment, Speed, And Quality Using eSource 1/3/2025

    Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.

  4. Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study 12/20/2024

    This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

  5. Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer 12/5/2024

    This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.

  6. A Thoughtful Copay Program Design That Increased Patient Engagement 11/26/2024

    Learn how a partnership with a pharmaceutical company to redesign patient support materials resulted in increased patient engagement and copay program utilization.

  7. Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia 11/20/2024

    Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.

  8. Improving Protocol Design With An Early Think-Tank Initiative 11/19/2024

    Explore how a client's first-in-human trial for a cancer drug was improved by using a think-tank approach and gap analysis, accelerating protocol design and streamlining development. 

  9. Supporting A One-Time Gene Therapy With A Population PD Model 11/19/2024

    How was predictive population PD modeling used to help a gene therapy for beta-thalassemia achieve FDA approval?

  10. Flexibility In Phase I ADC Drug Development 11/18/2024

    Learn how Worldwide Clinical Trials brings agility to Phase I trials for Antibody-Drug Conjugates (ADC). Discover strategies for adapting study protocols to meet the unique challenges of early-phase oncology research.